Topic Review
Triazolo-Thiadiazole Derivatives
The fusion of 1,2,4-triazole and 1,3,4-thiadiazole rings results in a class of heterocycles compounds with an extensive range of pharmacological properties. A series of 1,2,4-triazolo[3,4-b]-1,2,4-thiadiazoles was synthesized and tested for its enzyme inhibition potential and anticancer activity. The results show that 1,2,4-triazolo[3,4-b]-1,2,4-thiadiazoles display potent anticancer properties in vitro against a panel of cancer cells and in vivo efficacy in HT-29 human colon tumor xenograft in CB17 severe combined immunodeficient (SCID) mice.
  • 559
  • 20 Apr 2021
Topic Review
Tremor in Parkinson’s Disease with Mechanical Devices
Parkinsonian tremors are sometimes confused with essential tremors or other conditions. Researchers conducted several studies on tremor evaluation using wearable sensors and devices, which may support an accurate diagnosis. Mechanical devices are also commonly used to treat tremors and have been actively researched and developed. Mechanical devices for tremor suppression include deep brain stimulation (DBS), electrical muscle stimulation, and orthosis. Adaptive DBS and optimization of stimulation parameters have been studied to improve treatment efficacy further. Due to developments using state-of-the-art techniques, effectiveness in diagnosing, evaluating, and suppressing tremors using these devices is satisfactorily high in many studies.
  • 647
  • 09 Jan 2023
Topic Review
Tregs in Psoriasis
Psoriasis is a chronic inflammatory skin disease, which affects 2–4% of the population worldwide. Psoriasis has a strong genetic component, but environmental factors are also important. T-cell derived factors such as Psoriasis is characteristic, with thickening and scaling of the epidermisdue to hyper-proliferation of keratinocytes (acanthosis). CD4 and CD8 T-cell infiltrate characterizes the skin in psoriasis, a T-cell-driven disease, but other cell types are also present in the lesions, including neutrophils, macrophages, NK cells, dendritic cells. It has been long known that the pathogenesis of psoriasis is driven by T-cell derived factors, produced by subsets including T-helper (Th) 1 cells, Th17, Th22 and regulatory T cells (Tregs). 
  • 265
  • 27 Apr 2023
Topic Review
Treatments under Development of SARS-CoV-2
Coronaviridae is a single-strand, positive-sense, enveloped RNA virus family, circulating in many avian and mammal species hosts. In December 2019, a patient was found to have pneumonia caused by an unknown betacoronavirus. With the unbiased sample sequencing of the patient, a novel coronavirus was identified and named Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2, by the International Committee on Taxonomy of Viruses (ICTV).
  • 437
  • 29 Dec 2022
Topic Review
Treatments for Uremic Pruritus
Conventional treatments for uremic pruritus including emollient, topical agents, antihistamine, dialysis modification, phototherapy, and serotonin receptor antagonists.
  • 410
  • 25 May 2022
Topic Review
Treatments for PTSD
Posttraumatic stress disorder (PTSD) is a psychiatric disorder that can develop in certain individuals after exposure to traumatic events, such as combat and sexual assault. PTSD is commonly treated with various types of psychotherapy and pharmacotherapy.
  • 405
  • 25 Nov 2022
Topic Review
Treatments for Acute Intermittent Porphyria
Rare diseases, especially monogenic diseases, which usually affect a single target protein, have attracted growing interest in drug research by encouraging pharmaceutical companies to design and develop therapeutic products to be tested in the clinical arena. Acute intermittent porphyria (AIP) is one of these rare diseases. AIP is characterized by haploinsufficiency in the third enzyme of the heme biosynthesis pathway. Identification of the liver as the target organ and a detailed molecular characterization have enabled the development and approval of several therapies to manage this disease.
  • 449
  • 22 Dec 2022
Topic Review
Treatment Strategy for Intermediate-Stage Hepatocellular Carcinoma
Transarterial chemoembolization (TACE) has been standard treatment for intermediate-stage hepatocellular carcinoma (HCC). However, all intermediate-stage HCC patients did not benefit from TACE treatment because intermediate-stage HCC encompasses a wide variety of HCCs. Owing to remarkable progress in systemic therapy, including molecular-targeted therapy for advanced-stage HCC, the standard treatment of HCC has recently shifted to systemic therapy.
  • 264
  • 19 Jun 2023
Topic Review
Treatment Strategies of Epilepsy in Dravet Syndrome
Dravet Syndrome (DS) is a developmental epileptic encephalopathy characterized by drug-resistant seizures and other clinical features, including intellectual disability and behavioral, sleep, and gait problems. The pathogenesis is strongly connected to voltage-gated sodium channel dysfunction. The consensus of seizure management in DS consists of a combination of conventional and recently approved drugs such as stiripentol, cannabidiol, and fenfluramine. Despite promising results in randomized clinical trials and extension studies, the prognosis of the developmental outcomes of patients with DS remains unfavorable.
  • 275
  • 11 Apr 2023
Topic Review
Treatment Strategies in Chronic Myeloid Leukaemia
Chronic myeloid leukaemia (CML) is a type of blood cancer that is currently well-managed with drugs that target cancer-causing proteins. However, a significant proportion of CML patients do not respond to those drug treatments or relapse when they stop those drugs because the cancer cells in those patients stop relying on that protein and instead develop a new way to survive. Therefore, new treatment strategies may be necessary for those patients.
  • 567
  • 21 Jul 2022
  • Page
  • of
  • 1349
Video Production Service